Glenmede Trust’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-86,200
| Closed | -$965K | – | 2916 |
|
|
2017
Q3 | $965K | Sell |
86,200
-218,873
| -72% | -$2.45M | ﹤0.01% | 769 |
|
|
2017
Q2 | $2.99M | Hold |
305,073
| – | – | 0.01% | 571 |
|
|
2017
Q1 | $2.99M | Hold |
305,073
| – | – | 0.01% | 571 |
|
|
2016
Q4 | $3.29M | Hold |
305,073
| – | – | 0.02% | 531 |
|
|
2016
Q3 | $3.13M | Hold |
305,073
| – | – | 0.02% | 540 |
|
|
2016
Q2 | $3.98M | Sell |
305,073
-107,093
| -26% | -$1.4M | 0.02% | 492 |
|
|
2016
Q1 | $4.53M | Hold |
412,166
| – | – | 0.03% | 448 |
|
|
2015
Q4 | $3.79M | Hold |
412,166
| – | – | 0.03% | 477 |
|
|
2015
Q3 | $2.86M | Buy |
412,166
+52,926
| +15% | +$367K | 0.02% | 515 |
|
|
2015
Q2 | $3.53M | Buy |
359,240
+9,850
| +3% | +$96.7K | 0.03% | 451 |
|
|
2015
Q1 | $3.1M | Buy |
349,390
+123,110
| +54% | +$1.09M | 0.02% | 506 |
|
|
2014
Q4 | $1.98M | Buy |
+226,280
| New | +$1.98M | 0.02% | 572 |
|